SUN Pharmaceutical Industries Limited Tenofovir Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Tenofovir Export Records India — #9 Exporter, 43 Shipments, $2.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Tenofovir

India Pharmaceutical Trade Intelligence

$4.3B296 Suppliers182 CountriesHS 30049099

ExportsIndia → BOTSWANA73.3%India → TANZANIA6.1%

ImportsISRAEL → India$20.5M UNITED STATES → India$1.1M

#1 Buyer: AFRICURE PHARMACEUTICALS

SUN Pharmaceutical Industries Limited — Tenofovir Exporter #9 | $2.1M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Tenofovir Exporter Profile

Indian Pharmaceutical Exporter · #9 for Tenofovir · $2.1M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #9 Indian exporter of Tenofovir with $2.1M in export value and 43 verified shipments. SUN Pharmaceutical Industries Limited holds a 0.6% market share in Tenofovir exports across 15 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Tenofovir Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Tenofovir export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Tenofovir?

Country	Value	Shipments	Share
SOUTH AFRICA	$300.0K	8	24.4%
CAMEROON	$200.0K	4	16.3%
MOZAMBIQUE	$200.0K	5	16.3%
MYANMAR	$112.9K	7	9.2%
ANGOLA

Who Are the Top Buyers of Tenofovir from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
RANBAXY PHARMACEUTICALS PTY LTD.,	SOUTH AFRICA	$200.0K	4
RANBAXY PHARMACEUTICALS PTY LIMITED	SOUTH AFRICA	$100.0K	2
CENAME	CAMEROON	$100.0K	2
A. FERREIRA GOMES LDA, VAT - PT5000	ANGOLA	$68.5K	7
UNITE DE GESTION DES PROJETS UGP	CAMEROON	$50.0K	1
CENAME ON BEHALF OF THE MINISTRY	CAMEROON	$50.0K	1
NATIONAL MEDICAL STORES	KENYA	$50.0K	1
PRIMATURE UNITE DE GESTION DES	TOGO	$50.0K	1
MINISTERIO DA SAUDE CENTRAL DE	MOZAMBIQUE	$50.0K	1
MINISTRY OF HEALTH	MOZAMBIQUE	$50.0K	1

SUN Pharmaceutical Industries Limited supplies Tenofovir to 27 buyers globally. The largest buyer is RANBAXY PHARMACEUTICALS PTY LTD., (SOUTH AFRICA), followed by RANBAXY PHARMACEUTICALS PTY LIMITED (SOUTH AFRICA) and CENAME (CAMEROON). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Tenofovir Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
TELATRI TAB 50/300/300MG EACH FILM COATED TAB CONTAINS: DOLUTEGRAVIR 50MG LAMIVUDINE USP 300MG TENOFOVIR DISOPROXIL FU	$100.0K	2
TELATRI TAB 50/300/300MG EACH FILM COATED TAB CONTAINS: DOLUTEGRAVIR 50MG, LAMIVUDINE USP 300MG, TENOFOVIR DISOPROXIL FU	$100.0K	2
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABS 50/300/300MG EACH TAB CONTAINS DOLUTEGRAVIR 50MG,****	$68.5K	7
DLT DOLUTEGRAVIR LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TAB 50 300 300MGEACH TAB CONTAINS DOLUTEGRAVIR 50MG	$50.0K	1
LAMIVUDINE AND TENOFOVIR DF TABS 300/300	$50.0K	1
DLT DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TAB 50/300/300MG EACH TAB ***	$50.0K	1
DLT DOLUTEGRAVIR,LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TAB 50/300/300MGEACH TAB CONTAINS DOLUTEGRAVIR 50MG,***	$50.0K	1
DLT DOLUTEGRAVIR LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TAB 50/300/300MG EACH TABLET CONTAINS DOLUTEGRAVIR 50MG	$50.0K	1
DLIMITEDOLUTEGRAVIRLAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATETAB 50/300/300MG EACH TABLET CONTAINS ****	$50.0K	1
TENOFOVIR DISOPROXIL FUMARATE 300MG+ LAMIVUDINE 300MG+ DOLUTEGRAVIR SODIUM 50MGTABLETS75672 PACK X 90'S= 6810480 NOS	$50.0K	1

SUN Pharmaceutical Industries Limited exports 33 distinct Tenofovir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TELATRI TAB 50/300/300MG EACH FILM COATED TAB CONTAINS: DOLU with 2 shipments worth $100.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Tenofovir Exporters?

Exporters ranked immediately above and below #9 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
12	LUPIN LIMITED	$3.5M	70	4	$50.0K
8	APL HEALTHCARE LIMITED	$2.6M	53	10	$50.0K
9	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$2.1M	43	15	$50.0K
11	BHARAT PARENTERALS LIMITED	$1.4M	28	1	$50.0K
13	LAURUS LABS LTD	$400.0K	8	6	$50.0K

SUN Pharmaceutical Industries Limited ranks #9 among 296 Indian Tenofovir exporters. Average shipment value of $50.0K compared to the market average of $767.2K. The closest competitors by value are LUPIN LIMITED and APL HEALTHCARE LIMITED.

Which Indian Ports Ship Tenofovir Exports?

Port	Shipments	% Share
SAHAR AIR	1,351	18.0%
SAHAR AIR CARGO ACC (INBOM4)	1,121	14.9%
NHAVA SHEVA SEA (INNSA1)	526	7.0%
DELHI AIR CARGO ACC (INDEL4)	463	6.2%
HYDERABAD AIR	453	6.0%
DELHI AIR	433	5.8%
Bombay Air	371	4.9%
HYDERABAD ACC (INHYD4)	351	4.7%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Tenofovir Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Tenofovir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 47 individual customs records matching SUN Pharmaceutical Industries Limited exporting Tenofovir, covering 33 formulations to 17 countries via 27 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 182+ countries, 1,436+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Tenofovir

Tenofovir

SUN Pharmaceutical Industries Limited — Tenofovir Exporter Profile

SUN Pharmaceutical Industries Limited — Tenofovir Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Tenofovir?

Who Are the Top Buyers of Tenofovir from SUN Pharmaceutical Industries Limited?

What Is India's Total Tenofovir Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Tenofovir Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Tenofovir Exporters?

What Tenofovir Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Tenofovir to Key Markets

South Africa — SAHPRA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Tenofovir Exporters?

Which Indian Ports Ship Tenofovir Exports?

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Tenofovir Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Tenofovir Export Data from SUN Pharmaceutical Industries Limited

Tenofovir Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source